Private company
Adhera Therapeutics, Inc.
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2019
Where the money goes
Where each dollar of revenue went, fiscal 2019
- Cost of revenue37¢$409.0K
- Interest63¢$682.0K
Out of $252.0K in revenue.34 The company lost money this year.
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Revenue | $76.0K4 | $252.0K3 | ||
| Cost of revenue | $284.0K4 | $409.0K3 | ||
| Gross profit | -$208.0K4 | -$157.0K3 | ||
| Research and development | $132.5K5 | $907.5K6 | $241.0K4 | $04 |
| Operating income | -$757.7K5 | -$6.1M6 | -$15.8M4 | -$11.3M3 |
| Interest | $682.0K4 | |||
| Income tax | $8005 | $8006 | $04 | $04 |
| Net income | -$837.1K5 | -$6.2M6 | -$16.8M4 | -$12.0M3 |
| Earnings per share | -$1.644 | -$1.244 | ||
| Earnings per share (diluted) |
| Fiscal year | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Cash | $3.9M3 | $50.0K3 | ||
| Current assets | $316.5K5 | $124.9K6 | $4.7M4 | $420.0K3 |
| Total assets | $6.2M5 | $6.2M6 | $5.1M4 | $420.0K3 |
| Current liabilities | $3.0M5 | $5.7M6 | $2.2M4 | $10.3M3 |
| Total liabilities | $3.0M9 | |||
| Shareholders’ equity | $3.2M6 | $448.0K4 | $2.9M3 | -$9.9M10 |
| Shares outstanding | 9.0M shares5 | 10.5M shares6 | 10.8M shares4 | 10.9M shares3 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Former names
Recent filings
- Jan 18, 20248-K
- Jan 16, 20248-K
- Nov 29, 20238-K
- Nov 20, 202310-Q
- Oct 12, 20238-K
- Aug 21, 202310-Q
- Jun 29, 20238-K
- May 22, 202310-Q
- May 5, 20238-K
- May 4, 20238-K
- May 2, 202310-K/A
- Mar 31, 202310-K
- Mar 8, 20238-K
- Feb 23, 20238-K
- Jan 26, 20238-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10